- KOREAN
- P-ISSN3022-6805
- E-ISSN3022-6791
- KCI
ISSN : 3022-6805
A Clinico-epidemiological Profile of Dyslipidaemia and its Association with Temperament - A Cross Sectional Study
Mohammad Nawab (Department of Moalajat, National Research Institute of Unani Medicine for Skin Disorders)
M.H. Kazmi (National Research Institute of Unani Medicine for Skin Disorders)
Abstract
Introduction: Dyslipidaemia is directly associated with cardiovascular diseases. Temperament, the unique constitutional make-up of an individual, is responsible for one's personality traits, physical appearances, and disease predispositions. The rising prevalence of dyslipidaemia becomes a challenge to control morbidity and mortality due to cardiovascular diseases. Objective: To study clinical patterns and risk factors of dyslipidaemia and its association with temperament at the individual level was the main objective of this study. Materials and Methods: It was a descriptive and analytical cross sectional study. The participants (n=88) were screened on the basis of raised serum lipid profile from the outpatient department of National Research Institute of Unani Medicine for Skin Disorders, Hyderabad. The data were collected on a case record form designed for this study and analyzed retrospectively. Results: In this study, there were 57% participants (n=50) of phlegmatic temperament in which mean total cholesterol, triglycerides, low density lipoprotein- cholesterol and high density lipoprotein-cholesterol were 230.92 (±49.48) mg/dl, 182.34 (±110.61) mg/dl, 153.24 (±50.21) mg/dl and 46.3 (±10.83) mg/dl respectively. Discussion: This study showed the prevalence of different clinical patterns of dyslipidaemia in the population and the phlegmatic participants were dyslipidaemic in a higher percentage. The prevalence of dyslipidaemia in phlegmatic participants may be linked to the constitutional make-up of the individual. The temperament of an individual may be considered as one of the risk factors for dyslipidaemia. Conclusion: It was concluded that the temperament of an individual may be used as a screening tool to predict the individual’s tendency to develop dyslipidaemia.
- keywords
- Cardiovascular diseases, cholesterol, dyslipidaemia, obesity, temperament, Unani
Reference
Abd M, Goyfman M, Chaus A, Dabbous F, Tamura L, Sandfort V, Brown A, & Budoff M. The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis. Journal of Lipid Research, 2018;1–9.
Ahirwar R, & Mondal PR. Prevalence of obesity in India: A systematic review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2019;13;318–321. https://doi.org/10.1016/j.dsx.2018.08.032
Alam S, Alam A, Quamri MA, Sofi G, Khan MQ, & Ansari S. A Randomized single blind controlled clinical trial on safety and efficacy of a Unani formulation (Itrifal-e-Sagheer) in dyslipidemia. Tang [Humanituas Medicine],2020;10(1);4–10. http://dx.doi.org/10.5667/tang.2020.0008
Anonymous. Unani Medicine in India-An overview. (New Delhi, India: Central Council for Research in Unani Medicine), pp.25, 2016.
Bays HE, Toth PP, Kris-etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-campoy JM, Jones SR, Kumar R, Forge Rla & Samuel VT. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology, 2013;7;304–383.https://doi.org/10.1016/j.jacl.2013.04.001
Berawi KN, Hadi S, Lipoeto NI, Wahid I, & Jamsari. Dyslipidemia Incidents Between General Obesity and Central Obesity of Employees with Obesity at Universitas Lampung. Biomedical and Pharmacology Journal,2018;11(1);201–207. https://doi.org/10.13005/bpj/1364
Carr MC, & Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. Journal of Clinical Endocrinology and Metabolism, 2004;89(6);2601–2607. https://doi.org/10.1210/jc.2004-0432
Chang YC & Wu WC. Dyslipidemia and diabetic retinopathy. Review of Diabetic Studies, 2013;10(2–3);121–132. https://doi.org/10.1900/RDS.2013.10.121
Fodor G. Primary Prevention of CVD : Treating Dyslipidemia. American Family Physician, 2011;83(10); 1207–1208.
Garg R, Aggarwal S, Kumar R & Sharma G. Association of atherosclerosis with dyslipidemia and co-morbid conditions : A descriptive study. Journal of Natural Science, Biology and Medicine, 2015;6(1);163–168. https://doi.org/10.4103/0976-9668.149117
Hirano T. Pathophysiology of Diabetic Dyslipidemia. Journal of Atherosclerosis and Thrombosis,2018;25;771–782.
Hoosen M. Temperament-an important principle for health preservation in Tibb an-Nabawi and Unani-Tibb. Bangladesh Journal of Medical Science, 2017;16(4);487–495.
Karthikeyan G, Teo KK, Islam S, McQueen JM, Pais P, Wang X, Sato H, Lang chim choy, Amorn CS & Kazmi K. Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians. Journal of the American College of Cardiology,2009;53(3);244–253. https://doi.org/10.1016/j.jacc.2008.09.041
Kawanami D, Matoba K & Utsunomiya K. Dyslipidemia in diabetic nephropathy. Renal Replacement Therapy, 2016;2(16);1–9. https://doi.org/10.1186/s41100-016-0028-0
Mahalle N, Garg M, Naik S & Kulkarni M. Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Indian Journal of Endocrinology and Metabolism,2014;18(1);48–55. https://doi.org/10.4103/2230-8210.126532
Munjal YP. API Textbook of Medicine (9th ed.). (The Association of Physicians of India), 2012
Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K & Kawada T. Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population. Journal of the American Heart Association,2016;5(3);1–9. https://doi.org/10.1161/JAHA.115.003053
Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V & Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. Journal of Clinical Epidemiology,2000;53(4);393–400. https://doi.org/10.1016/S0895-4356(99)00184-5
Pretis Nde, Amodio A & Frulloni L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterology Journal, 2018;6(5);649–655. https://doi.org/10.1177/2050640618755002
Saeed AA. Anthropometric predictors of dyslipidemia among adults in Saudi Arabia. Epidemiology Biostatistics and Public Health, 2013;10(1);1–11. https://doi.org/10.2427/8733
Sarkar P, Mahadeva SK, Raghunath H, Nimisha V & Mandela TS. Utility of Anthropometric Indices as a Predictor of Dyslipidemia. Journal of Medical Sciences and Health, 2015;01(03); 10–13. https://doi.org/10.46347/jmsh.2015.v01i03.003
WHO. The Global Health Observatory. World Health Organisation; World Health Organization, 2011. Available at: https://www.who.int/data/gho/data/themes/theme-details/GHO/body-mass-index-(bmi)[Accessed on 5th December 2020]
WHO. Global Health Observatory (GHO) data, 2016. Available at: https://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/ [Accessed on 5th December 2020]
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations